|
1 Indications And Usage Prezcobix ® Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus (hiv-1) Infection In Treatment-Naïve And Treatment-Experienced Adults And Pediatric Patients Weighing At Least 40 Kg With No Darunavir Resistance-Associated Substitutions (v11i, V32i, L33f, I47v, I50v, I54l, I54m, T74p, L76v, I84v, L89v). Prezcobix Is A Two-Drug Combination Of Darunavir, A Human Immunodeficiency Virus (hiv-1) Protease Inhibitor, And Cobicistat, A Cyp3a Inhibitor, And Is Indicated For The Treatment Of Hiv-1 Infection In Treatment-Naïve And Treatment-Experienced Adults And Pediatric Patients Weighing At Least 40 Kg With No Darunavir Resistance-Associated Substitutions (v11i, V32i, L33f, I47v, I50v, I54l, I54m, T74p, L76v, I84v, L89v). ( 1 )
|